A carregar...
Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer
Oncogene-addicted non-small cell lung cancer (NSCLC) patients have been witnessing overwhelming therapeutic improvements, especially in advanced disease management, due to the advent of more potent tyrosine kinase inhibitors (TKIs). However, the concrete chance to cure anaplastic lymphoma kinase (AL...
Na minha lista:
| Publicado no: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894993/ https://ncbi.nlm.nih.gov/pubmed/31857952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.07.07 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|